Melanins with improved ability to inhibit hiv replication

Details Melanins with improved ability to inhibit hiv replication Melanins with improved ability to inhibit hiv replication

A - Human Necessities

61

K

A61K 31/195 (2006.01) A61K 31/00 (2006.01) A61K 31/40 (2006.01) A61K 31/785 (2006.01) C12P 17/00 (2006.01)

Patent

CA 2280178

Novel enzymatically produced melanins are described that are useful in the treatment of HIV infection. The novel melanins are optionally modified to contain chemical moieties such as halogens, sulfates, or sulfonyl groups. Additionally, the novel enzymatically synthesized melanins may be modified, or further modified, by chemical oxidation.

L'invention concerne de nouvelles mélanines résultant d'une synthèse enzymatique, qui sont utiles pour le traitement de l'infection par le HIV. Lesdites mélanines sont éventuellement modifiées pour renfermer des fractions chimiques (par exemple, halogènes, sulfates ou groupes sulfonyle). De plus, on peut modifier ces mélanines, ou les modifier de manière complémentaire, en les soumettant à une oxydation chimique.

Affiliated with

Also associated with

Rating

Melanins with improved ability to inhibit hiv replication does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanins with improved ability to inhibit hiv replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanins with improved ability to inhibit hiv replication will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1609725